Six Points of Miscommunication Between Oncologists and Pathologists
Regardless of where you practice, good communication between you and your pathologist is the best way to ensure that correct testing is done. Here are six common points of miscommunication to watch out for.
References:
1. Janne PA. What Are We Talking About: Next-Generation Sequencing, Sanger Sequencing, etc. Presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting.
2. Aisner D. Tissue is the Issue: The Pathologist’s Role in Facilitating Molecular Analysis. Presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting.
3. Nowak JA. The Practitioner's Guide to Using Molecular Testing. Presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting.
Addition of Capivasertib to Paclitaxel Fails to Improve OS in Metastatic TNBC
September 13th 2024The phase 3 CAPItello-290 trial of capivasertib plus paclitaxel did not meet its primary end point of improved overall survival in the frontline setting of metastatic triple-negative breast cancer.
